12 mg Retatrutide Dosage Calculator

In a 10 mg/mL vial, 12 mg retatrutide equals 120 units. The calculation is (12 / 10) x 100 = 120 units. This exceeds a standard 100-unit syringe, so you would need either a larger syringe or a higher concentration vial.

Phase 2 research reported meaningful average weight changes among participants on the 12 mg dose at 48 weeks, with larger effects at higher doses. Retatrutide is investigational and has not been compared head-to-head against other medications, so cross-product comparisons should be avoided. Long-term efficacy and safety are still being evaluated in Phase 3 trials.

The clinical trial protocol reaches 12 mg at week 17 after escalating through 1 mg (weeks 1-4), 2 mg (weeks 5-8), 4 mg (weeks 9-12), and 8 mg (weeks 13-16). This 16-week titration period allows the body to adjust gradually to the potent triple-receptor agonist mechanism before reaching the maximum studied dose.

Semaglutide, tirzepatide, and retatrutide act on progressively more receptor targets — GLP-1 alone, GIP plus GLP-1, and GIP plus GLP-1 plus glucagon, respectively. Retatrutide's additional glucagon receptor activity is thought to affect energy expenditure and fat oxidation alongside appetite suppression. Retatrutide is investigational, has not been studied head-to-head against the others, and lacks their long-term data, so direct comparisons should be avoided.